Wei Zhang
- Cancer Research top 2%
- MicroRNA in disease regulation 15
- Cancer-related molecular mechanisms research 13
- Cancer, Hypoxia, and Metabolism 11
- Immunology top 5%
- Immunotherapy and Immune Responses 29
- Oncology top 5%
- CAR-T cell therapy research 12
- Molecular Biology top 5%
- RNA modifications and cancer 17
- RNA Interference and Gene Delivery 10
- Infectious Diseases top 5%
-
- Tracheal and airway disorders 11
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Cell (1 paper)Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Zhang
245 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 156
- Cancer Research 831
- Immunology 754
- Oncology 847
- Molecular Biology 2.0k
- Infectious Diseases 475
Countries citing papers authored by Wei Zhang
This map shows the geographic impact of Wei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Zhang more than expected).
Fields of papers citing papers by Wei Zhang
This network shows the impact of papers produced by Wei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Zhang. The network helps show where Wei Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 7 | |
| 13 | 2020 | 4 | |
| 14 | 2019 | 115 | |
| 15 | 2012 | 1 | |
| 16 | 2012 | 14 | |
| 17 | 2012 | 21 | |
| 18 | Binary Mixed Solvents for Separating Benzene-Cyclohexane by Extractive Distillation | 2006 | 2 |
| 19 | Extraction and identification of barley #alpha#-amylase/subtilisin inhibitor | 2005 | 1 |
| 20 | Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. | 1997 | 121 |
About Wei Zhang
Wei Zhang is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 264 papers that have together received 4.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (29 papers), RNA modifications and cancer (17 papers), MicroRNA in disease regulation (15 papers), Cancer-related molecular mechanisms research (13 papers), CAR-T cell therapy research (12 papers), Tracheal and airway disorders (11 papers), Cancer, Hypoxia, and Metabolism (11 papers) and RNA Interference and Gene Delivery (10 papers). The work is most often cited by research in Cancer Research (831 citations), Immunology (754 citations) and Oncology (847 citations). Wei Zhang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Sheng‐Ming Dai, Wenhe Zhu, Haidong Huang, Dingjun Zhu, Mei Ye, Xiaoping Su, Xi Wang, Peng Zhou, Yunye Ning and Lei Zhang. Their work appears in journals such as Cell, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.